We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4523:TSEEisai Co., Ltd. Analysis

Data as of 2026-06-17 - not real-time

₩2,890.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Capstone Partners is trading at 2,890 KRW, well below its 20‑day SMA of 3,174 and near the identified support level of 2,700, suggesting a potential bounce zone. The RSI of 33 signals that the stock is oversold, while the MACD remains bearish with a minimal histogram gap, indicating lingering downside momentum. Volume is on a decreasing trend, and the 30‑day volatility is high at nearly 49%, which amplifies short‑term price swings. Fundamentally, the firm shows strong gross and operating margins but reports zero EBITDA and negative operating cash flow, a debt‑to‑equity ratio of 14.6, and a price‑to‑sales multiple of 5.53, raising concerns about earnings sustainability. The dividend yield sits at 1% with a modest payout ratio of 17%, yet cash generation is weak, questioning the dividend’s durability. Market sentiment is extremely bullish (Fear & Greed Index 91.9, “Extreme Greed”), but the lack of analyst coverage and a zero PE ratio suggest the price may be inflated relative to earnings prospects. Overall, the stock sits at a technical crossroads with upside potential if it can hold support, but fundamental and valuation pressures remain prominent.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Oversold RSI indicating potential near‑term price correction
  • Proximity to technical support level at 2,700 KRW
  • High short‑term volatility offering rapid swing opportunities

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated debt‑to‑equity ratio limiting financial flexibility
  • Negative operating cash flow and zero EBITDA reducing earnings confidence
  • Modest dividend yield with sustainability concerns

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Overvaluation reflected by high price‑to‑sales multiple and zero PE
  • Weak cash generation and high leverage undermining long‑term viability
  • Sector and regulatory headwinds in the asset‑management space

Key Metrics & Analysis

Financial Health

Revenue Growth2.80%
Profit Margin32.32%
ROE7.16%
ROA6.04%
Debt/Equity14.57
Op. Cash Flow₩-546348224
Industry P/E17.3

Technical Analysis

TrendNeutral
RSI33.0
Support₩2,700.00
Resistance₩3,735.00
MA 20₩3,174.25
MA 50₩3,895.30
MA 200₩3,207.60
MACDBearish
VolumeDecreasing
Fear & Greed Index91.93

Valuation

GradeOvervalued
TypeBlend
Dividend Yield1.00%

Risk Assessment

Beta-0.34
Volatility48.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.